REVIEW PAPER
Common variable immunodeficiency disorders – diseases with many faces
More details
Hide details
Publication date: 2018-06-07
Pediatr Pol 2018;93(2):186-191
KEYWORDS
ABSTRACT
Common variable immunodeficiency disorders (CVID) are the most frequent symptomatic primary immunodeficiency condition in children and adults. The main problem of patients suffering from this disorder is the variety of clinical symptoms, which delays the diagnosis and thus institution of appropriate treatment. The authors present varied medical signs that may suggest CVID and diagnostic methods that can facilitate the final diagnosis.
CVID can manifest with various phenotypes: infectious, autoimmune, lymphoproliferative, and neoplastic. CVID is the most common compilation of all four clinical pictures. The basic examinations can be made in a Primary Care Physician Clinic: complete blood count with blood smear, proteinogram gammaglobulin levels, and concentration of immunoglobulins in the main classes. The epigenetic factors and genetic studies have become increasingly important due to the variety of clinical manifestations. These examinations speed up the final diagnosis.
The treatment of CVID is based on the intravenous or subcutaneous substitution of immunoglobulins.
Antibiotics, immunosuppressive and biological treatment, and even bone morrow stem cell transplantation are sometimes required.
Due to diagnostic difficulties, the diagnosis of CVID is delayed. The patients often need medical and multi-specialist assistance without obtaining a definitive diagnosis. Meanwhile early diagnosis will allow appropriate therapy and will protect the patients against complications.
REFERENCES (26)
1.
Lankisch P, Schiffner J, Ghosh S i wsp. The Duesseldorf warning signs for primary immunodeficiency: is it time to change the rules? J Clin Immunol 2015; 35: 273-279.
2.
Maarschalk-Ellerbroek LJ, Hoepelman AlM, van Montfrans JM i wsp. The Spectrum of Disease Manifestations in Patients with Common Variable Immunodeficiency Disorders and Partial Antibody Deficiency in a University Hospital. J Clin Immunol 2012; 32: 907-921.
3.
Cooper CJ, Said S, Quansah R i wsp. Pneumococcal meningitis in a young adult female with common variable immunodeficiency. Am J Case Rep 2013; 14: 471-475.
4.
Jolles S. The variable in common variable immunodeficiency: a disease of complex phenotypes. J Allergy Clin Immunol Pract 2013; 1: 545-556.
5.
Abolhassani H, Sagvand BT, Shokuhfar T i wsp. A review on guidelines for management and treatment of common variable immunodeficiency. Expert Rev Clin Immunol 2013; 9: 561-574.
6.
Gathmann B, Mahlaoui N, Gérard L i wsp. European Society for Immunodeficiencies Registry Working Party: Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol 2014; 134: 116-126.
7.
Sekinaka Y, Mitsuiki N, Imai K i wsp. Common Variable Immunodeficiency Caused by FANC Mutations. J Clin Immunol 2017; 37: 434-444.
8.
Azizi G, Abolhassani H, Mahdaviani SA i wsp. Clinical, immunologic, molecular analyses and outcomes of iranian patients with LRBA deficiency: A longitudinal study. Pediatr Allergy Immunol 2017; 28: 478-484.
9.
Warnatz K, Bossaller L, Salzer U i wsp. Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood 2006; 107: 3045-3052.
10.
Cunningham-Rundles C. The many faces of common variable immunodeficiency. Hematology Am Soc Hematol Educ Program 2012; 2012: 301-305.
11.
Ameratunga R, Brewerton M, Slade C i wsp. Comparison of Diagnostic Criteria for Common Variable Immunodeficiency Disorder. Front Immunol 2014; 5: 415.
12.
Conaway E. Novel variant of common variable immunodeficiency. BMJ Case Rep 2017 May 27. doi: 10.1136/bcr-2017-219655.
13.
Patuzzo G, Barbieri A, Tinazzi E i wsp. Autoimmunity and infection in common variable immunodeficiency (CVID). Autoimmun Rev 2016; 15: 877-882.
14.
Mohammadinejad P, Aghamohammadi A, Abolhassani H i wsp. Pediatric patients with common variable immunodeficiency: long-term follow-up. J Investig Allergol Clin Immunol 2012; 22: 208-214.
15.
Roliński J, Grywalska E. Alergia czy zmienny pospolity niedobór odporności? Manifestacje płucne, skórne i pokarmowe CVID. alergia.org.pl (dostęp: 10.08.2017).
16.
Azizi G, Tavakol M, Rafiemanesh H i wsp. Autoimmunity in a cohort of 471 patients with primary antibody deficiencies. Expert Rev Clin Immunol 2017; 13: 1099-1106.
17.
Dhalla F, da Silva SP, Lucas M. Review of gastric cancer risk factors in patients with common variable immunodeficiency disorders, resulting in a proposal for a surveillance programme. Clin Exp Immunol 2011; 165: 1-7.
18.
Tak Manesh A, Azizi G, Heydari A i wsp. Epidemiology and pathophysiology of malignancy in common variable immunodeficiency? Allergol Immunopathol (Madr) 2017 Apr 12. doi: 10.1016/j.aller.2017.01.006.
19.
Szczawinska-Poplonyk A, Tapolska-Jozwiak K, Samara H. The B-cell compartment in antibody-deficient infants and young children – developing common variable immunodeficiency or transient immune maturation? Ital J Pediatr 2016; 42: 71.
21.
Rae W. Indications to Epigenetic Dysfunction in the Pathogenesis of Common Variable Immunodeficiency. Arch Immunol Ther Exp (Warsz) 2017; 65: 101-110.
22.
Salzer U, Warnatz K, Peter HH. Common variable immunodeficiency: an update. Arthritis Res Ther 2012; 14: 223.
23.
Gobert D, Bussel JB, Cunningham-Rundles C i wsp. Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients. Br J Haematol 2011; 155: 498-508.
24.
Pac M, Bernatowska E. Comprehensive activities to increase recognition of primary immunodeficiency and access to immunoglobulin replacement therapy in Poland. Eur J Pediatr 2016; 175: 1099-1105.
25.
Prieto Elordui J, Arreba Gonzalez P, Ortiz de Zarate Sagastagoitia J i wsp. Infliximab as treatment of severe enteropathy in a patient with common variable immunodeficiency and cytomegalovirus infection. Gastroenterol Hepatol 2017 May 2. doi: 10.1016/j.gastrohep.2017.03.002.
26.
Akazawa Y, Takeshima F, Yajima H i wsp. Infliximab therapy for Crohn’s-like disease in common variable immunodeficiency complicated by massive intestinal hemorrhage: a case report. BMC Res Notes 2014; 7: 382.